Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    VolitionRx

    MCap

    USD76m

    Last close

    USD0.81

    ▲ 0.14 (20.90%)

    Canyon Resources

    MCap

    AUD262m

    Last close

    AUD0.19

    ▲ 0.02 (12.12%)

    Immix Biopharma

    MCap

    USD51m

    Last close

    USD1.82

    ▲ 0.12 (7.06%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Aditxt: Edison Open House Healthcare 2022

Aditxt: Edison Open House Healthcare 2022

Aditxt — 2 videos in collection

More on this equity

Aditxt is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring.

• Tell us about the company’s product development strategy.
• Can you tell us about AditxtScore for COVID-19 and the information it provides that you wouldn’t get from either antigen or PCR testing?
• How has AditxtScore been received in the marketplace and which organisations are using the platform?
• Please update us on the situation around the emergency use application (EUA) for AditxtScore and how important this is for your business.
• What are some of the potential advantages of your Apoptotic DNA Immunotherapy (ADI)?
• Which milestones should investors focus on in the coming year?

< Previous
Next >

You may also be interested in these:

Healthcare

Aditxt business update with Amro Albanna, co-founder and CEO

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free